Geoffrey Stiller, MD
Surgery · Spokane, WANPI 1952345514
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 43 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. AbbVie accounts for 83.3% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2024 at $328 and has fallen 72.6% since, to $90 in 2025. That places this record below the midpoint for surgery clinicians in WA, where the typical reported total is $1,310.
Across 43 payments — averaging $25.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$899
- Mentor Worldwide LLC$110
- Merz North America, Inc.$36
- Revance Therapeutics, Inc.$19
- Johnson & Johnson$16
What the payments were for
- Food & beverage$1,079100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 35 | $899 |
| Mentor Worldwide LLC | 4 | $110 |
| Merz North America, Inc. | 2 | $36 |
| Revance Therapeutics, Inc. | 1 | $19 |
| Johnson & Johnson | 1 | $16 |
How this compares
$1,079 in reported general payments places this provider in the 45th percentile of 549 surgery providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ibuprofen | 13 | $98 |
| Ondansetron Hcl | 11 | $70 |
| Oxycodone Hcl | 11 | $67 |
Paid to pharmacies, not to this prescriber.
Other surgery in Spokane
- David BrownSpokane$94K
- Mathew RawlinsSpokane$41K
- Matthew KleinSeattle$328K
- Kevin CliveSilverdale$289K
- Adnan AlseidiSeattle$240K
- Prakash GattaTacoma$212K
- Aileen HwangIssaquah$195K
- Rajeev MisraSilverdale$183K
- Amir BastawrousSeattle$131K
- Alejandro ArnoldCovington$131K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.